Ac-SSO110 has now received FDA orphan drug designation and investigational new drug application clearance for the treatment ...
News Medical on MSN1d
Ariceum Therapeutics receives FDA’s Orphan Drug Designation for targeted radionuclide cancer treatmentAriceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, today announced that the U.S. Food ...
This report is required reading for: Investors that want to understand the impact key review designations like Orphan Drug Designations could have on companies. Professional Services that are ...
has granted Orphan Drug Designation (ODD) to its proprietary radiopharmaceutical, 225Ac-satoreotide, for treating patients with Small Cell Lung Cancer (SCLC). SCLC is a severe condition with a poor ...
Company prepares to advance to Phase 2 clinical trial in early 2025HOUSTON, Jan. 28, 2025 (GLOBE NEWSWIRE) -- March Biosciences (March Bio), an ...
MB-105, a first-in-class CD5-targeted CAR T-cell therapy, received FDA orphan drug designation for relapsed/refractory T-cell ...
Seed Therapeutics Inc.’s ST-01156 has been awarded orphan drug designation for the treatment of Ewing sarcoma as well as rare pediatric disease designation by the FDA.
SEED Therapeutics announced that the U.S. Food and Drug Administration has granted Rare Pediatric Disease and Orphan Drug designations to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback